This article has Open Peer Review reports available.
Factors influencing preoperative stress response in coronary artery bypass graft patients
© Morin et al; licensee BioMed Central Ltd. 2004
Received: 17 June 2004
Accepted: 23 September 2004
Published: 23 September 2004
In many studies investigating measures to attenuate the hemodynamic and humoral stress response during induction of anaesthesia, primary attention was paid to the period of endotracheal intubation since it has been shown that even short-lasting sympathetic cardiovascular stimulation may have detrimental effects on patients with coronary artery disease. The aim of this analysis was, however, to identify the influencing factors on high catecholamine levels before induction of anaesthesia.
Various potential risk factors that could impact the humoral stress response before induction of anaesthesia were recorded in 84 males undergoing coronary aortic bypass surgery, and were entered into a stepwise linear regression analysis. The plasma level of norepinephrine measured immediately after radial artery canulation was chosen as a surrogate marker for the humoral stress response, and it was used as the dependent variable in the regression model. Accordingly, the mean arterial blood pressure, heart rate and the calculated pressure-rate product were taken as parameters of the hemodynamic situation.
Stepwise regression analysis revealed that the oral administration of low-dose clonidine (mean dose 1.75 μg·kg-1) on the morning of surgery was the only significant predictor (p = 0.004) of the high variation in preoperative norepinephrine plasma levels. This intervention decreased norepinephrine levels by more than 40% compared to no clonidine administration, from 1.26 to 0.75 nmol·l-1. There was no evidence for dose-responsiveness of clonidine. All other potential predictors were removed from the model as insignificant (p > 0.05). The use of beta-blocker, ace-inhibitors, ejection fraction, and body mass index were significant determinants for the hemodynamic situation (heart rate, mean arterial pressure, pressure rate product) of the patient during the pre-induction period.
The oral administration of clonidine is the only significant predictor for the observed variation of norepinephrine levels during the preoperative period. Lack of significant dose responsiveness suggests that even a low dose of the drug can attenuate the preoperative stress response and thus is recommended in cardiovascular high risk patients.
There is increasing evidence that sympathetic nervous system mediated cardiovascular stimulation with increased catecholamine blood levels is the principal mechanism responsible for perioperative tachycardia and hypertension, myocardial ischemia and infarction [1–3]. Even short-lived changes may have detrimental effects on the coronary circulation of high-risk patients, with higher rates of morbidity and lethality [4, 5]. Thus, many studies have concentrated on the stressful stimulus of endotracheal intubation, and a number of pharmacological attempts have been used to attenuate the hemodynamic response, including the use of high doses of opioids, α2-adrenergic receptor agonists, β-adrenergic blocking drugs or other antihypertensive drugs [3, 4, 6–19].
However, little attention has been paid to the stress response of cardiac high risk patients when entering the operating area, during initiation of routine monitoring, and finally during awake venous and arterial canulation. Especially the latter procedure can cause significant discomfort for patients even when performed under local anaesthesia . In several trials a high inter-individual variation of pre-induction norepinephrine levels, heart rate and blood pressure could be noticed . Thus, this observational analysis was performed in patients undergoing coronary aortic bypass surgery (CABG-surgery) in order to identify patients at high risk for increased sympathoadrenergic stress response during the immediate preoperative period using norepinephrine levels and the hemodynamic status as surrogate measures.
After Ethics Committee approval was obtained, patients gave their written and informed consent. Eighty-four consecutive male patients undergoing CABG-surgery were enrolled into this observational study. The only exclusion criterion was emergency operation.
General anaesthesia was standardized. After administration of midazolam 0.05 mg·kg-1 and a three minute period of preoxygenation, anaesthesia was induced using a continuous infusion of propofol (10 mg·kg-1.h-1) and sufentanil (10 μg.kg-1.h-1). After loss of consciousness propofol was reduced to 3 mg·kg-1.h-1 and sufentanil to 1.5 μg·kg-1.h-1. Endotracheal intubation was performed after administration of pancuronium bromide 0.1 mg·kg-1.
To allow comprehensive analysis of potential factors associated with a reduced stress response, the following data were recorded prospectively:
Body mass index (BMI)
Clorazepate dose per kilogram bodyweight
Clonidine (yes – no)
Clonidine per kilogram bodyweight
Time from morning premedication until observational period
Inhibitors of the angiotensine converting enzyme system (ace-inhibitors)
Angiotensin-2 receptor inhibitors
Left ventricular ejection fraction (EF)
Number of affected vessels
A power analysis had revealed that 80 patients provide a power of more than 95% to detect an R2 of 0.3 and higher, attributed to 14 independent variables using an F-test with a significance level of 0.05. All potential relevant factors were subjected to a stepwise linear regression analysis using a backward technique. In each step the least significant factor was eliminated when F was lower than 3.96. The quality of the regression model was judged using the Durbin-Watson statistic (a value between 0 and 4 indicating the amount of autocorrelation within the model with an optimum of 2.0), and by checking if the standardized residuals are normally distributed. All calculations were performed using SPSS 11.0 for Windows. All continuous data are presented as mean and standard deviation when normally distributed and as median (25th–75th percentile) when normal distribution had to be rejected using the Kolmogorov-Smirnov-test.
Stepwise regression analysis revealed that the single administration of low-dose clonidine (mean dose 1.75 μg·kg-1) on the morning of surgery was the only significant predictor (p = 0.004) of the high variation in preoperative norepinephrine plasma levels. This intervention decreased norepinephrine levels by 40% compared to no clonidine administration (from 1.26 to 0.75 nmol·l-1). In this analysis, the dichotomous variable (clonidine administration: yes-no) was a better predictor for the norepinephrine levels than variables including the clonidine dose (absolute dose or dose per body weight), indicating that our data provide no evidence for a strong dose-responsiveness of clonidine in this context.
All other of the investigated factors (see methods) were removed from the regression model as not significant. The two factors that were eliminated with a p < 0.1 during the last but one and during the final step were body mass index (removed in step 11 with a p = 0.064) and age (removed in step 12 with a p = 0.076). Both factors were associated with increased norepinephrine levels.
The overall quality of the regression model was excellent. The Durbin-Watson coefficient was 2.04 (very near to the optimum of 2.0) and the standardized residuals were normally distributed.
For mean arterial blood pressure, heart rate and the calculated pressure rate product, however, preoperative clonidine administration was not an influencing factor.
For the mean arterial pressure (MAP), a higher ejection fraction (EF) was a statistically significant predictor (p = 0.024). Each 10% increase of EF was associated with a 2.7 mmHg higher MAP. Administration of an ace-inhibitor was the second predictor in the final model of MAP (p = 0.03). These patients had a 7.5 mmHg lower MAP than patients without ace-inhibitors.
For heart rate (HR) there were three significant predictors that remained in the model. Administration of beta-blockers and ace-inhibitors were both associated with a decreased HR (p = 0.004). Each of them decreased HR between 6–7 beats per minute (bpm). Additionally, a higher BMI was associated with a 1.3 bpm higher HR per kg·m-2 (p = 0.001).
Since the PRP is the product of HR and MAP, it is not surprising that similar variables contributed to its prediction. These were the administration of beta-blockers (p = 0.017) and ace-inhibitors (p = 0.004), each of them reducing the PRP, whereas the EF was associated with an increase in PRP (p = 0.014).
No patient had signs of cardiac ischemia on arrival at the operating theatre until induction of anaesthesia (defined as ST-T change > 0.1 mV in any ECG lead). There were no major adverse events during the entire induction period and surgery.
The α2-adrenergic receptor agonist clonidine acts by decreasing central sympathetic nervous system activity in all hyperadrenergic situations. In addition to its sedative, anxiolytic, analgesic and antihypertensive properties [6, 22] it has shown to improve congestive heart failure, to optimize the myocardial oxygen supply / demand ratio in ischemic heart disease [23, 24] and to reduce attacks of angina pectoris [25, 26].
In many investigations attention has been drawn to the stressful stimulus of endotracheal intubation [3, 4, 6–19], as it has been shown that even short-lasting sympathetic cardiovascular stimulation may have detrimental effects on the coronary circulation of patients with coronary artery disease (CAD), with higher rates of morbidity and lethality [4, 5], However, little emphasis has been paid to the preoperative period where patients may be stressed by or because of the upcoming procedure. Furthermore, transfer to the operating theatre, initiation of routine monitoring, and venous and arterial canulations are stressors for the patients. In this context it is certainly a drawback of our study that we did not record the level of preoperative sedation or anxiolysis using clinical measurements on appropriate scales. Instead of this, only a rough judgment was made (awake versus asleep but rousable) that did not allow a valid analysis of the data. Previous data, however, have shown potent anxiolytic and sedative properties of the drug .
Thus, it was the major aim of this observational study to identify factors that might contribute either to increased humoral stress or that might help to attenuate this response.
Patients' demographic data and preoperative condition. Data are presented for all 84 patients that were included in the study, and separately for those patients receiving clonidine and those without oral clonidine premedication. Values are expressed as mean ± standard deviation, median (25th–75th percentile), or n = (%).
Patients with clonidine morning premedication
Patients without clonidine morning premedication
n = 84
n = 42
n = 42
66 ± 9
65 ± 9
67 ± 8
82 ± 10
82 ± 11
82 ± 10
173 ± 6
173 ± 6
173 ± 5
BMI (kg · m-2)
27.3 ± 3.1
27.3 ± 3.2
27.4 ± 3.0
62 ± 14
61 ± 13
63 ± 16
Affected vessels (n = / %)
n = 1
n = 2
n = 3
n = 4
Pre-treated with (n= / %)
Clonidine dose (n= / %)
Time from morning premedication
until observational period (hours)
Heart rate [bpm]
66 ± 11
66 ± 10
66 ± 12
Mean arterial blood pressure [mmHg]
102 ± 16
100 ± 15
104 ± 17
Pressure rate product [mmHg·bpm]
6750 ± 1640
6660 ± 1600
6850 ± 1690
Plasma norepinephrine level (nmol·l-1)
1.00 ± 0.82
0.75 ± 0.48
1.26 ± 1.00
However, it is interesting to notice that the mean dose administered to our patients (1.75 μg·kg-1) was low compared to all other trials. Data concerning the appropriate dose of clonidine to attenuate the stress response to intubation vary considerably between 0.625 and 10 μg·kg-1. For example, one trial demonstrated that clonidine 0.625 and 1.25 μg·kg-1 i.v. were sufficient to attenuate pressure response to laryngoscopy and intubation , whereas in another one  evaluating the dose-response effects to laryngoscopy and intubation, 2 μg·kg-1 clonidine i.v. was equally effective as placebo, and only 4 and 6 μg·kg-1 significantly attenuated hemodynamic and adrenergic reactions in an equal manner. It could also be shown that 4 or 6 μg·kg-1 were necessary to reduce norepinephrine levels before induction of anaesthesia, however 2 μg·kg-1 where not sufficient in this setting .
In our trial as well as in all other studies with even much higher doses, clonidine was well tolerated and did not produce any adverse hemodynamic effects.
In our analysis there was no strong evidence for a dose responsiveness of orally administered clonidine. First, in the regression model catecholamine levels could better be predicted by the dichotomous variable and second, there was only a weak correlation between the weight adjusted clonidine dose on the one hand and norepinephrine levels on the other hand (Pearson's correlation coefficient was -0.31, Spearman's rank correlation coefficient was -0.30). Furthermore, a post-hoc comparison between the patients receiving either 75 or 150μg clonidine did not show relevant differences (p = 0.91 using the Mann-Whitney U-test).
Higher age and higher body mass index showed a non-significant tendency to increase the catecholamine concentration. No other of the investigated factors (body weight, height, time from morning premedication until observational period, benzodiazepine dose per kilogram bodyweight, ace-inhibitors, beta-blocking drugs, calcium antagonists, EF, number of affected vessels) had statistically significant impact on norepinephrine levels.
An explorative post-hoc analysis of the impact of clonidine premedication (none versus any dose) and clonidine dose on norepinephrine levels during the entire induction period proves the results of the main analysis. There was a pronounced reduction of norepinephrine plasma levels after induction of general anaesthesia with lower values in the clonidine-group. However, a statistically significant interaction term (p = 0.012) suggests that the fall of norepinephrine levels are more marked in the untreated group and thus mainly caused by induction of general anaesthesia rather than effects of clonidine (figure 1).
This observational trial demonstrates that patients undergoing coronary artery bypass graft surgery have a great variation of norepinephrine levels when entering the operating theatre. We could identify oral clonidine premedication as the only predictor for increased humoral stress response. There was no strong evidence for a dose dependency, indicating that even small doses, like 75–150 μg attenuate the humoral stress response before coronary artery bypass graft surgery. Clonidine did not have a negative impact on hemodynamic parameters.
- Frank SM, Beattie C, Christopherson R: Epidural versus general anesthesia, ambient operating room temperature, and patient age as predictors of inadvertent hypothermia. Anesthesiology. 1992, 77: 252-257.View ArticlePubMedGoogle Scholar
- Beattie WS, Buckley DN, Forrest JB: Epidural morphine reduces the risk of postoperative myocardial ischemia in patients with cardial risk factors. Can J Anaesth. 1993, 40: 532-541.View ArticlePubMedGoogle Scholar
- Howie MB, Hiestand DC, Jopling MW, Romanelli VA, Kelly WB, McSweeney TD: Effect of oral clonidine premedication on anesthetic requirement, hormonal response, hemodynamics, and recovery in coronary artery bypass graft surgery patients. J Clin Anesth. 1996, 8: 263-272. 10.1016/0952-8180(96)00033-5.View ArticlePubMedGoogle Scholar
- Edwards ND, Alford AM, Dobson PMS, Peacock JE, Reilly CS: Myocardial ischemia during tracheal intubation and extubation. Br J Anaesth. 1994, 73: 537-539.View ArticlePubMedGoogle Scholar
- Choyce A, Avidan MS, Harvey A, Patel C, Timberlake C, Sarang K, Tilbrook L: The cardiovascular response to insertion of the intubating laryngeal mask airway. Anaesthesia. 2002, 57: 330-333. 10.1046/j.1365-2044.2002.02463.x.View ArticlePubMedGoogle Scholar
- Flacke JW, Bloor BC, Flacke WE: Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology. 1987, 67: 11-19.View ArticlePubMedGoogle Scholar
- Helbo-Hansen S, Fletcher R, Lundberg D: Clonidine and the sympatico-adrenal response to coronary artery bypass surgery. Acta Anaesthesiol Scand. 1986, 30: 235-242.View ArticlePubMedGoogle Scholar
- Ghignone M, Quintin L, Duke PC: Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology. 1986, 64: 36-42.View ArticlePubMedGoogle Scholar
- Segal IS, Jarvis DJ, Duncan SR: Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. Anesthesiology. 1991, 74: 220-225.View ArticlePubMedGoogle Scholar
- Quinton L, Roudot F, Roux C: Effect of clonidine on the circulation and vasoactive hormones after aortic surgery. Br J Anaesth. 1991, 66: 108-115.View ArticleGoogle Scholar
- Engelman E, Lipszyc M, Gilbart E: Effects of clonidine on anesthetic drug requirements and hemodynamic response during aortic surgery. Anesthesiology. 1989, 71: 178-187.View ArticlePubMedGoogle Scholar
- Dorman BH, Zucker JR, Verrier ED, Gartman DM, Slachman FN: Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coranary arterie bypass surgery. J Cardiothorac Vasc Anesth. 1993, 7: 386-395. 10.1016/1053-0770(93)90157-G.View ArticlePubMedGoogle Scholar
- Dorman T, Clarkson K, Rosenfeld B, Shanholtz C, Lipsett PA, Breslow MJ: Effects of clonidine on prolonged postoperative sympathetic response. Critical Care Medicine. 1997, 25: 1147-1152. 10.1097/00003246-199707000-00015.View ArticlePubMedGoogle Scholar
- Boussofara M, Bracco D, Ravussin P: Comparison of the effects of clonidine and hydroxyzine on haemodynamic and catecholamine reactions to microlaryngoscopy. European Journal of Anaestehsiology. 2001, 18: 75-78. 10.1046/j.1365-2346.2001.00782.x.View ArticleGoogle Scholar
- Nishikawa T, Taguchi M, Kimura T, Taguchi N, Sato Y, Dai M: Effects of clonidine premedication upon hemodynamic changes associated with laryngoscopy and tracheal intubation. Masui. 1991, 40: 1083-1088.PubMedGoogle Scholar
- Chadha R, Padmanabhan V, Joseph A, Mohandas K: Oral clonidine pretreatment for heamodynamic stability during craniotomy. Anaesth Intensive Care. 1992, 20: 341-344.PubMedGoogle Scholar
- Laurito CE, Baughman VL, Becker GL, DeSilva TW, Carranza CJ: The effectiveness of oral clonidine as a sedative/anxiolytic and as a drug to blunt the hemodynamic response to laryngoscopy. J Clin Anesth. 1991, 3: 186-193. 10.1016/0952-8180(91)90157-I.View ArticlePubMedGoogle Scholar
- Zalunardo MP, Zollinger A, Szelloe P, Spahn DR, Seifert B, Pasch T: Kardiovaskulaere Stressprotektion waehrend der Anaesthesieeinleitung. Anaesthesist. 2001, 50: 21-25. 10.1007/s001010050958.View ArticlePubMedGoogle Scholar
- Kulka PJ, Tryba M, Zenz M: Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesth Analg. 1995, 80: 263-268. 10.1097/00000539-199502000-00011.PubMedGoogle Scholar
- Giner J, Casan P, Belda J, Gonzalez M, Miralda RM, Sanchis J: Pain during arterial puncture. Chest. 1996, 110: 1443-1445.View ArticlePubMedGoogle Scholar
- Kahl M, Eberhart LHJ, Behneke H, Sänger S, Schwarz U, Vogt S, Moosdorf R, Wulf H, Geldner G: Stress response to tracheal intubation in patients undergoing coronary artery surgery. Direct laryngoscopy vs. intubating laryngeal mask airway. J Cardiothorac Vasc Anesth. 2004, : 275-280. 10.1053/j.jvca.2004.03.005.Google Scholar
- Jarrott B, Conway EL, Maccarrone C, Lewis SJ: Clonidine: understanding its disposition, sites and mechanism of action. Clin Exp Pharmacol Physiol. 1987, 14: 471-479.View ArticlePubMedGoogle Scholar
- Giles TD, Iteld BJ, Mautner RK, Rognomi PA, Dillenkoffer RL: Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther. 1981, 30: 724-728.View ArticlePubMedGoogle Scholar
- Giles TD, Thomas MG, Quiroz A, Rice JC, Plauche W, Sander GE: Acute and short-term effects of clonidine in heart failure. Angiology. 1987, 38: 537-548.View ArticlePubMedGoogle Scholar
- Ceremuzynski I, Zaleka T, Lada W, Zalewski A: Clonidine effect in chronic angina pectoris. Double-blind, crossover trial on 60 patients. Eur J Cardiol. 1979, 10: 415-427.PubMedGoogle Scholar
- Thomas MG, Quiroz AC, Rice JC: Antianginal effects of clonidine. J Cardiovasc Pharmacol. 1986, 8 (Suppl 3): S69-S75.View ArticleGoogle Scholar
- Frank T, Wehner M, Heinke W, Schmadicke I: [Clonidine vs. Midazolam for premedication - comparison of the anxiolytic effect by using the STAI-test]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002, 37: 89-93. 10.1055/s-2002-20395.View ArticlePubMedGoogle Scholar
- Carabine UA, Allen RW, Moore J: Partial attenuation of the pressor response to endotracheal intubation. A comparison of the effects of intravenous clonidine and fentanyl. European Journal of Anaestehsiology. 1992, 9: 325-329.Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2253/4/7/prepub
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.